A new therapeutic agent discovered and developed at The Ohio State University will soon be used for cancer treatment at the patient’s bedside as part of a clinical trial.
Ohio State’s novel DHODH inhibitor enters first human trials
- Post author:
- Post published:September 17, 2024
- Post category:uncategorized